| Literature DB >> 34938723 |
Wentao Shu1, Yinan Wang1,2, Xi Zhang3, Chaoyang Li4, Hanxiang Le4, Fei Chang4.
Abstract
The therapy of burns is a challenging clinical issue. Burns are long-term injuries, and numerous patients suffer from chronic pain. Burn treatment includes management, infection control, wound debridement and escharotomy, dressing coverage, skin transplantation, and the use of skin substitutes. The future of advanced care of burn wounds lies in the development of "active dressings". Hydrogel dressings have been employed universally to accelerate wound healing based on their unique properties to overcome the limitations of existing treatment methods. This review briefly introduces the advantages of hydrogel dressings and discusses the development of new hydrogel dressings for wound healing along with skin regeneration. Further, the treatment strategies for burns, ranging from external to clinical, are reviewed, and the functional classifications of hydrogel dressings along with their clinical value for burns are discussed.Entities:
Keywords: antibacterial; burn wound; emergency temporary coverage; factors promoting wound healing; hydrogel dressing; stem cells
Year: 2021 PMID: 34938723 PMCID: PMC8685951 DOI: 10.3389/fbioe.2021.788461
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Burn wounds. (A) First degree. (B) Superficial second degree. (C) Deep second degree. (D) Third degree.
FIGURE 2Classification of burn dressings: Traditional dressings, Natural biological dressings, and Synthetic dressings.
FIGURE 3Functional classification of hydrogel dressings for burns: Imitating extracellular matrix hydrogel, Hydrogel loaded with stem cells, Hydrogel loaded with healing promoting factors, and New technology of hydrogel dressing.
Summary of commonly employed polymers in hydrogel dressings and their functions in wound management.
| Function | Main polymer | Bioactive agent | Burn depth | Function in wounds | Ref. |
|---|---|---|---|---|---|
| First aid | Carbomer 940 | Full-thickness burn wounds | Nontoxic, improves tissue perfusion, reduces area of necrotic tissue in burn wounds |
| |
| Natural silk fibroin | Full-thickness burn wounds | Promotes wound healing, facilitates the transition from the inflammation stage to the proliferation stage |
| ||
| Hydrazidemodified hyaluronic acid (HAAD)/benzaldehyde-terminated F127 triblock copolymer | Deep partial-thickness burn models | Adaptable mechanical strength, self-healing, liquid absorption/drainage, tissue adhesion, promotes repair of burn wounds |
| ||
| Bacterial cellulose/acrylic acid (BC/AA) | Skin-burn wounds | Non-toxic, promotes wound-healing, enhances epithelialization, accelerates fibroblast proliferation | ( | ||
| Amphiphilic chitosan-g-pluronic copolymer | Curcumin | Second- and third-degree burn-wound models | Enhances regenerated collagen density, results in the formation of a thicker epidermis layer, increases collagen content, improves granulation, increases wound maturity, and enhances wound closure |
| |
| Dextran | Full-thickness burn wounds | Promotes neovascularization and skin regeneration | ( | ||
| MPEG-PCL micelles/α- cyclodextrin | Dexamethasone sodium phosphate/Avastin® | Alkali-burn models in rats | High ocular biocompatibility and non-irritating after topical instillation, attenuates alkali burn-induced corneal inflammation, suppresses corneal neovascularization |
| |
| Polyvinyl alcohol/agar | Icariin | Full-thickness burn wounds | Promotes new translucent skin tissue, repairs the ECM, enhances wound healing |
| |
| HA/CCS/HLC | Skin burns on the backs of rabbits | Prevents bacterial infection effectively, promotes burn-wound healing better than a commercial film (DuoDERM®) |
| ||
| CMC-Na/SA/CS | Second-degree burn wounds | Excellent self-regulatory and anti-adhesive properties that promote the healing of burn wounds synergistically |
| ||
| Gelatin/alginate | Burn wounds on skin | Good biocompatibility and cell-attachment properties |
| ||
| Lysine-based dendron/PEG | Wounds from second-degree burns | Dissolves “on demand” through the thiol–thioester exchange reaction, allowing the burn dressing to be removed readily |
| ||
| CMC/rigid rod-like dialdehyde-modified cellulose nanocrystal | Skin-burn wounds | Injected into an irregular deep burn wound, it reforms rapidly into an integrated piece, completely filling the wound area. Amino-acid solution can be used to dissolve the hydrogel, allowing painless dressing removal |
| ||
| Keratin-chitosan | Nano-ZnO | Skin-burn wounds | Increases swelling, exhibits bactericidal activity |
| |
| Anti-bacterial | Silver sulfadiazine-bFGF | Partial-thickness burn wounds( | Non-toxic and safe |
| |
| MC | Silver oxide NPs | Second-degree burns | Excellent antimicrobial activity and healing of burn wounds |
| |
| Agarose | Minocycline/gentamicin | Porcine burn models | Reduces burn depth and the number of bacteria |
| |
| Poloxamer (F68/F127) | Boron | Second-degree burn wounds | Increases wound closure |
| |
| Chitosan | Moxiflfloxacin | Animals with bacterial loads | Shows better efficacy than conventional gels in |
| |
| Dextran-hyaluronic acid | Sanguinarine | Full-thickness burn infection model (MRSA, | Improves re-epithelialization, enhances ECM remodeling |
| |
| Hyaluronic acid/chondroitin sulfate/asiatic acid | Zinc oxide/copper oxide | Second-degree burn wounds | Non-toxic; exhibits significant antibacterial activity, promotes re-epithelization, collagen-fiber arrangement, and angiogenesis; shows significant wound-healing activity |
| |
| Glycol chitosan | Colistin | Burn-infection model in animals | Performs almost as well as native colistin against colistin-sensitive and colistin-resistant |
| |
| Carbomer | Ciprofloxacin and lidocaine | Models of second-degree burns | Reduces the wound-healing period, increases the number of fibroblasts, increases the rates of epithelialization and dermis reconstruction, has an immediate anesthetic effect |
| |
| Collagen |
| Full-thickness burn wounds | Improves the morphological and biomechanical characteristics of burn wounds |
| |
| Chiosan | Marine peptides | Burn wounds on the backs of rabbits | Enhances cell migration and promotes skin regeneration |
| |
| Loading with stem cells | BC/AA | Human epidermal keratinocytes/human dermal fibroblasts | Burn wounds in thymic-free mice | Has significant collagen deposition |
|
| Polysaccharide | MSCs | Alkali burns to the corneas of rats | Enhances the migration rate of primarily cultured corneal epithelial cells; improves the recovery of the corneal epithelium; reduces inflammation, neovascularization, and opacity of the healed cornea |
| |
| UArg-PEA (chitosan derivative) | MSCs | Wounds from third-degree burns | Promotes wound closure, re-epithelialization, granulation-tissue formation, and vascularization |
| |
| Chitosan/collagen/β-glycerophosphate | MSCs | Wounds from third-degree burns | Shortens healing time, limits the inflammation area, enhances re-epithelialization, promotes formation of high-quality, well-vascularized granulation tissue, attenuates formation of fibrotic, and hypertrophic scar tissue |
| |
| PEGylated fibrin chitosan/microspheres (SSD-CSM-FPEG) | Silver sulfadiazine | Burn wounds on rats infected with | Reduces bacterial infection and promotes neo-vascularization with improved matrix remodeling |
| |
| Loading with wound healing-promoting factors | Hyaluronic acid, dextran, and β-cyclodextrin | Resveratrol/VEGF plasmid | Model of splinted excisional wounds in rats | Inhibits the inflammatory response and promotes microvascular formation while being biocompatible |
|
| Recombinant human granulocyte/macrophage colony-stimulating factor | Deep partial-thickness burn wounds | Promotes healing effectively |
| ||
| Others | Rabbit collagen | Human amnion | Second-degree burns in rats | Non-cytotoxic, accelerates wound healing based on complete re-epithelialization and closure by wound contraction |
|
| Honey | Burn-induced wounds in mice | 75% honey–chitosan hydrogel possesses greater wound healing activity compared with that of commercial treatment and can be used safely as an effective natural treatment for topical wound healing |
| ||
| Sea cucumber | Burn-induced wounds in mice | Stimulates tissue regeneration and regulation of pro-inflammatory cytokines |
| ||
| Alginate | PWD | Burn-induced wounds in pigs | Safely delivers high concentrations of antibiotics in a hydrogel and treats burn infections |
|
FIGURE 4“On demand” dissolvable hydrogels for the healing of deep partial-thickness burns. (A) How on-demand dissolvable self-healing hydrogels are used to treat wounds (schematic). (B) Representative images of wound sites in each treatment group over time. (C) Unclosed wound area rate of initial wound as a function of time. ns p > 0.05, *p ≤ 0.05, **p ≥ 0.01, ***p ≤ 0.001. Reproduced with permission from (Huang et al., 2018).
FIGURE 5Hydrogel-based localized release of colistin for antimicrobial treatment of infections from burn wounds. (A) Treatment of a burn wound with a colistin-loaded hydrogel (schematic). (B) Synthesis of a colistin-containing hydrogel (schematic). (C) Disk diffusion assay of a colistin-loaded hydrogel against colistin-sensitive (left) and colistin-resistant (right) P. aeruginosa strains (D) Test of colistin-loaded hydrogel against colistin-sensitive (left) and colistin-resistant (right) strains of P. aeruginosa in a model of burn infection. Reproduced with permission from (Zhu et al., 2017).
FIGURE 6Delivery of silver sulfadiazine and adipose-derived stem cells using fibrin hydrogel improves infected burn wounds. (A) Photographs of the burn device and burn wound. (B) Burn wounds treated with SSD-CSM-ASC-FPEG had significantly thicker granulation tissue than those treated with SSD-CSM-FPEG. (C) SSD-CSM-ASC-FPEG facilitates neo-vascularization on day-21. p < 0.05. (D) Maturation of collagen. Picrosirius staining images on day-28. Reproduced with permission from (Banerjee et al., 2019).
FIGURE 7In situ-formed anti-inflammatory hydrogel loaded with plasmid DNA encoding VEGF for healing of burn wounds. (A) Application of this hydrogel in a model of a splinted excisional wound (schematic). (B) Immunohistochemical staining showing expression of the proinflammatory cytokines IL-1β and TNF-α. (C) Immunohistochemical staining showing expressions of the angiogenic factors VEGF, CD31, and α-SMA. Scale bar = 100 μm. (D) RT-qPCR of mRNA expression for inflammatory and angiogenic factors (IL-1β, TNF-α, VEGF). **p ≤ 0.01, *p ≤ 0.05. Reproduced with permission from (Wang et al., 2019).